Journal of Molecular and Cellular Cardiology
Volume 48, Issue 3 , Pages 490-496 , March 2010

Contribution of extracellular matrix to the mechanical properties of the heart

  • Gregory M. Fomovsky

      Affiliations

    • Department of Biomedical Engineering, Columbia University, New York, NY, USA
    • ,
  • Stavros Thomopoulos

      Affiliations

    • Departments of Orthopaedic Surgery and Biomedical Engineering, Washington University, St. Louis, MO, USA
    • ,
  • Jeffrey W. Holmes

      Affiliations

    • Departments of Biomedical Engineering and Medicine, Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VA, USA
    • Corresponding Author InformationCorresponding author. Department of Biomedical Engineering, Box 800759, Health System, Charlottesville, VA 22908, USA. Tel.: +1 434 243 6321; fax: +1 434 982 3870.

Received 11 May 2009 ,Revised 8 July 2009 ,Accepted 4 August 2009.

References 

  1. Sacks MS. Incorporation of experimentally-derived fiber orientation into a structural constitutive model for planar collagenous tissues. J. Biomech. Eng. 2003;125(2):280–287
  2. Liao J, Yang L, Grashow J, Sacks MS. Molecular orientation of collagen in intact planar connective tissues under biaxial stretch. Acta. Biomater. 2005;1(1):45–54
  3. Weber KT. Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll. Cardiol. 1989;13(7):1637–1652
  4. Bing OH, Matsushita S, Fanburg BL, Levine HJ. Mechanical properties of rat cardiac muscle during experimental hypertrophy. Circ. Res. 1971;28(2):234–245
  5. Villari B, Campbell SE, Hess OM, Mall G, Vassalli G, Weber KT, et al. Influence of collagen network on left ventricular systolic and diastolic function in aortic valve disease. J. Am. Coll. Cardiol. 1993;22(5):1477–1484
  6. Weber KT, Brilla CG, Janicki JS. Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc. Res. 1993;27(3):341–348
  7. Borg TK, Ranson WF, Moslehy FA, Caulfield JB. Structural basis of ventricular stiffness. Lab. Invest. 1981;44(1):49–54
  8. Bing OH, Fanburg BL, Brooks WW, Matsushita S. The effect of the lathyrogen beta-amino proprionitrile (BAPN) on the mechanical properties of experimentally hypertrophied rat cardiac muscle. Circ. Res. 1978;43(4):632–637
  9. Kato S, Spinale FG, Tanaka R, Johnson W, Cooper GT, Zile MR. Inhibition of collagen cross-linking: effects on fibrillar collagen and ventricular diastolic function. Am. J. Physiol. 1995;269(3 Pt 2):H863–H868
  10. MacKenna DA, Omens JH, McCulloch AD, Covell JW. Contribution of collagen matrix to passive left ventricular mechanics in isolated rat hearts. Am. J. Physiol. 1994;266(3 Pt 2):H1007–H1018
  11. Todaka K, Jiang T, Chapman JT, Gu A, Zhu SM, Herzog E, et al. Functional consequences of acute collagen degradation studied in crystalloid perfused rat hearts. Basic. Res. Cardiol. 1997 Jun;92(3):147–158
  12. Stroud JD, Baicu CF, Barnes MA, Spinale FG, Zile MR. Viscoelastic properties of pressure overload hypertrophied myocardium: effect of serine protease treatment. Am. J. Physiol. Heart. Circ. Physiol. 2002;282(6):H2324–H2335
  13. Granzier HL, Irving TC. Passive tension in cardiac muscle: contribution of collagen, titin, microtubules, and intermediate filaments. Biophys. J. 1995;68(3):1027–1044
  14. Badenhorst D, Maseko M, Tsotetsi OJ, Naidoo A, Brooksbank R, Norton GR, et al. Cross-linking influences the impact of quantitative changes in myocardial collagen on cardiac stiffness and remodelling in hypertension in rats. Cardiovasc. Res. 2003;57(3):632–641
  15. Lopez B, Querejeta R, Gonzalez A, Beaumont J, Larman M, Diez J. Impact of treatment on myocardial lysyl oxidase expression and collagen cross-linking in patients with heart failure. Hypertension. 2009;53(2):236–242
  16. Aronson D. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J. Hypertens. 2003;21(1):3–12
  17. Holmes JW, Borg TK, Covell JW. Structure and mechanics of healing myocardial infarcts. Annu. Rev. Biomed. Eng. 2005;7:223–253
  18. Chapman D, Weber KT, Eghbali M. Regulation of fibrillar collagen types I and III and basement membrane type IV collagen gene expression in pressure overloaded rat myocardium. Circ. Res. 1990;67(4):787–794
  19. Pauschinger M, Knopf D, Petschauer S, Doerner A, Poller W, Schwimmbeck PL, et al. Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio. Circulation. 1999;99(21):2750–2756
  20. Cleutjens JP, Verluyten MJ, Smiths JF, Daemen MJ. Collagen remodeling after myocardial infarction in the rat heart. Am. J. Pathol. 1995;147(2):325–338
  21. Pope AJ, Sands GB, Smaill BH, LeGrice IJ. Three-dimensional transmural organization of perimysial collagen in the heart. Am. J. Physiol. Heart. Circ. Physiol. 2008;295(3):H1243–H1252
  22. Dokos S, Smaill BH, Young AA, LeGrice IJ. Shear properties of passive ventricular myocardium. Am. J. Physiol. Heart. Circ. Physiol. 2002;283(6):H2650–H2659
  23. Schmid H, O'Callaghan P, Nash MP, Lin W, LeGrice IJ, Smaill BH, et al. Myocardial material parameter estimation: a non-homogeneous finite element study from simple shear tests. Biomech. Model. Mechanobiol. 2008;7(3):161–173
  24. Costa KD, Holmes JW, McCulloch AD. Modeling cardiac mechanical properties in three dimensions. Phil. Trans. R. Soc. Lond. A. 2001;359:1233–1250
  25. MacKenna DA, Vaplon SM, McCulloch AD. Microstructural model of perimysial collagen fibers for resting myocardial mechanics during ventricular filling. Am. J. Physiol. 1997 Sep;273(3 Pt 2):H1576–H1586
  26. Thomopoulos S, Fomovsky GM, Holmes JW. The development of structural and mechanical anisotropy in fibroblast populated collagen gels. J. Biomech. Eng. 2005;127(5):742–750
  27. Thomopoulos S, Fomovsky GM, Chandran PL, Holmes JW. Collagen fiber alignment does not explain mechanical anisotropy in fibroblast populated collagen gels. J. Biomech. Eng. 2007;129(5):642–650
  28. Elbjeirami WM, Yonter EO, Starcher BC, West JL. Enhancing mechanical properties of tissue-engineered constructs via lysyl oxidase crosslinking activity. J. Biomed. Mater. Res. A. 2003;66(3):513–521
  29. Girton TS, Oegema TR, Tranquillo RT. Exploiting glycation to stiffen and strengthen tissue equivalents for tissue engineering. J. Biomed. Mater. Res. 1999;46(1):87–92
  30. Shadwick RE. Mechanical design in arteries. J. Exp. Biol. 1999;202(Pt 23):3305–3313
  31. Milnor WR. Hemodynamics. Baltimore: Williams & Wilkins; 1982;
  32. Bergel DH. The dynamic elastic properties of the arterial wall. J. Physiol. 1961;156(3):458–469
  33. Izzo JL, Mitchell GF. Aging and arterial structure–function relations. Adv. Cardiol. 2007;44:19–34
  34. Roach MR, Burton AC. The reason for the shape of the distensibility curves of arteries. Can. J. Biochem. Physiol. 1957;35(8):681–690
  35. Gleason RL, Humphrey JD. A 2D constrained mixture model for arterial adaptations to large changes in flow, pressure and axial stretch. Math. Med. Biol. 2005;22(4):347–369
  36. Sato S, Ashraf M, Millard RW, Fujiwara H, Schwartz A. Connective tissue changes in early ischemia of porcine myocardium: an ultrastructural study. J. Mol. Cell. Cardiol. 1983;15(4):261–275
  37. Henderson BC, Sen U, Reynolds C, Moshal KS, Ovechkin A, Tyagi N, et al. Reversal of systemic hypertension-associated cardiac remodeling in chronic pressure overload myocardium by ciglitazone. Int. J. Biol. Sci. 2007;3(6):385–392
  38. Cheng XW, Obata K, Kuzuya M, Izawa H, Nakamura K, Asai E, et al. Elastolytic cathepsin induction/activation system exists in myocardium and is upregulated in hypertensive heart failure. Hypertension. 2006;48(5):979–987
  39. Mujumdar VS, Tyagi SC. Temporal regulation of extracellular matrix components in transition from compensatory hypertrophy to decompensatory heart failure. J. Hypertens. 1999;17(2):261–270
  40. Jobsis PD, Ashikaga H, Wen H, Rothstein EC, Horvath KA, McVeigh ER, et al. The visceral pericardium: macromolecular structure and contribution to passive mechanical properties of the left ventricle. Am. J. Physiol. Heart. Circ. Physiol. 2007;293(6):H3379–H3387
  41. Wagenseil JE, Ciliberto CH, Knutsen RH, Levy MA, Kovacs A, Mecham RP. Reduced vessel elasticity alters cardiovascular structure and function in newborn mice. Circ. Res. 2009;104(10):1217–1224
  42. Faury G, Pezet M, Knutsen RH, Boyle WA, Heximer SP, McLean SE, et al. Developmental adaptation of the mouse cardiovascular system to elastin haploinsufficiency. J. Clin. Invest. 2003;112(9):1419–1428
  43. Mizuno T, Yau TM, Weisel RD, Kiani CG, Li RK. Elastin stabilizes an infarct and preserves ventricular function. Circulation. 2005;112(9 Suppl):I81–I88
  44. Mow VC, Ratcliffe A. Structure and function of articular cartilage and meniscus. In:  Mow VC,  Hayes WC editor. Basic Orthopaedic Biomechanics. Philadelphia: Lippincott-Raven; 1997;p. 113–177
  45. Akizuki S, Mow VC, Muller F, Pita JC, Howell DS, Manicourt DH. Tensile properties of human knee joint cartilage: I. Influence of ionic conditions, weight bearing, and fibrillation on the tensile modulus. J. Orthop. Res. 1986;4(4):379–392
  46. Armstrong CG, Mow VC. Variations in the intrinsic mechanical properties of human articular cartilage with age, degeneration, and water content. J. Bone. Joint. Surg. Am. 1982;64(1):88–94
  47. Kempson GE, Muir H, Swanson SA, Freeman MA. Correlations between stiffness and the chemical constituents of cartilage on the human femoral head. Biochim. Biophys. Acta. 1970;215(1):70–77
  48. Setton LA, Elliott DM, Mow VC. Altered mechanics of cartilage with osteoarthritis: human osteoarthritis and an experimental model of joint degeneration. Osteoarthritis. Cartilage. 1999;7(1):2–14
  49. Harris ED, Parker HG, Radin EL, Krane SM. Effects of proteolytic enzymes on structural and mechanical properties of cartilage. Arthritis. Rheum. 1972;15(5):497–503
  50. Zhu W, Mow VC, Koob TJ, Eyre DR. Viscoelastic shear properties of articular cartilage and the effects of glycosidase treatments. J. Orthop. Res. 1993;11(6):771–781
  51. Azeloglu EU, Albro MB, Thimmappa VA, Ateshian GA, Costa KD. Heterogeneous transmural proteoglycan distribution provides a mechanism for regulating residual stresses in the aorta. Am. J. Physiol. Heart. Circ. Physiol. 2008;294(3):H1197–H1205
  52. Bereczki E, Santha M. The role of biglycan in the heart. Connect. Tissue. Res. 2008;49(3):129–132
  53. May-Newman K, McCulloch AD. Homogenization modeling for the mechanics of perfused myocardium. Prog. Biophys. Mol. Biol. 1998;69(2-3):463–481
  54. Lanir Y, Hayam G, Abovsky M, Zlotnick AY, Uretzky G, Nevo E, et al. Effect of myocardial swelling on residual strain in the left ventricle of the rat. Am. J. Physiol. 1996;270(5 Pt 2):H1736–H1743
  55. Mjaatvedt CH, Yamamura H, Capehart AA, Turner D, Markwald RR. The Cspg2 gene, disrupted in the hdf mutant, is required for right cardiac chamber and endocardial cushion formation. Dev. Biol. 1998;202(1):56–66
  56. Watanabe H, Kimata K, Line S, Strong D, Gao LY, Kozak CA, et al. Mouse cartilage matrix deficiency (cmd) caused by a 7 bp deletion in the aggrecan gene. Nat. Genet. 1994;7(2):154–157
  57. Costell M, Carmona R, Gustafsson E, Gonzalez-Iriarte M, Fassler R, Munoz-Chapuli R. Hyperplastic conotruncal endocardial cushions and transposition of great arteries in perlecan-null mice. Circ. Res. 2002;91(2):158–164
  58. Danielson KG, Baribault H, Holmes DF, Graham H, Kadler KE, Iozzo RV. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J. Cell. Biol. 1997;136(3):729–743
  59. Xu T, Bianco P, Fisher LW, Longenecker G, Smith E, Goldstein S, et al. Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat. Genet. 1998;20(1):78–82
  60. Weis SM, Zimmerman SD, Shah M, Covell JW, Omens JH, Ross J, et al. A role for decorin in the remodeling of myocardial infarction. Matrix. Biol. 2005;24(4):313–324
  61. Campbell PH, Hunt DL, Jones Y, Harwood F, Amiel D, Omens JH, et al. Effects of biglycan deficiency on myocardial infarct structure and mechanics. Mol. Cell. Biomech. 2008;5(1):27–35
  62. Westermann D, Mersmann J, Melchior A, Freudenberger T, Petrik C, Schaefer L, et al. Biglycan is required for adaptive remodeling after myocardial infarction. Circulation. 2008;117(10):1269–1276
  63. Braunlin EA, Berry JM, Whitley CB. Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I. Am. J. Cardiol. 2006;98(3):416–418

PII: S0022-2828(09)00325-3

doi: 10.1016/j.yjmcc.2009.08.003

Journal of Molecular and Cellular Cardiology
Volume 48, Issue 3 , Pages 490-496 , March 2010

Article Tools

* Image Usage & Resolution